Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit.
Høilund-Carlsen PF, Alavi A, Barrio JR, Castellani RJ, Costa T, Herrup K, Kepp KP, Neve RL, Perry G, Revheim ME, Robakis NK, Sensi SL, Vissel B. Høilund-Carlsen PF, et al. Ageing Res Rev. 2024 Aug;99:102348. doi: 10.1016/j.arr.2024.102348. Epub 2024 Jun 1. Ageing Res Rev. 2024. PMID: 38830549 Review.
Re: Aducanumab-Related ARIA: Paean or Lament?
Høilund-Carlsen PF, Alavi A, Revheim ME. Høilund-Carlsen PF, et al. Clin Nucl Med. 2023 Jun 1;48(6):505-506. doi: 10.1097/RLU.0000000000004509. Epub 2023 Feb 1. Clin Nucl Med. 2023. PMID: 36724162 Free PMC article. No abstract available.
NaF-PET Imaging of Atherosclerosis Burden.
Høilund-Carlsen PF, Piri R, Gerke O, Sturek M, Werner TJ, Revheim ME, Alavi A. Høilund-Carlsen PF, et al. J Imaging. 2023 Jan 30;9(2):31. doi: 10.3390/jimaging9020031. J Imaging. 2023. PMID: 36826950 Free PMC article. Review.
The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.
Kepp KP, Sensi SL, Johnsen KB, Barrio JR, Høilund-Carlsen PF, Neve RL, Alavi A, Herrup K, Perry G, Robakis NK, Vissel B, Espay AJ. Kepp KP, et al. J Alzheimers Dis. 2023;94(2):497-507. doi: 10.3233/JAD-230099. J Alzheimers Dis. 2023. PMID: 37334596
Passive Alzheimer's immunotherapy: A promising or uncertain option?
Høilund-Carlsen PF, Revheim ME, Costa T, Alavi A, Kepp KP, Sensi SL, Perry G, Robakis NK, Barrio JR, Vissel B. Høilund-Carlsen PF, et al. Ageing Res Rev. 2023 Sep;90:101996. doi: 10.1016/j.arr.2023.101996. Epub 2023 Jul 5. Ageing Res Rev. 2023. PMID: 37414156 Review.
383 results